168 related articles for article (PubMed ID: 7579380)
21. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
22. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.
Ott G; Kalla J; Ott MM; Schryen B; Katzenberger T; Müller JG; Müller-Hermelink HK
Blood; 1997 Feb; 89(4):1421-9. PubMed ID: 9028966
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes.
Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J
Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110
[TBL] [Abstract][Full Text] [Related]
24. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
[TBL] [Abstract][Full Text] [Related]
25. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK
J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 overexpression in malignant lymphomas.
Nakamura S; Yatabe Y; Seto M
Pathol Int; 1997 Jul; 47(7):421-9. PubMed ID: 9234379
[TBL] [Abstract][Full Text] [Related]
27. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
[TBL] [Abstract][Full Text] [Related]
28. MBR rearrangement and P-glycoprotein expression are not independent prognostic factors like p53 protein in malignant lymphoma.
Sun RX; Coste J; Segara C; Rousset T; Fabbro M; Rème T; Legouffe E; Klein B; Rossi JF
Clin Lab Haematol; 1998 Apr; 20(2):87-94. PubMed ID: 9681218
[TBL] [Abstract][Full Text] [Related]
29. The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status.
Mansukhani MM; Osborne BM; Zhong J; Matsushima AY
Diagn Mol Pathol; 1997 Aug; 6(4):222-8. PubMed ID: 9360843
[TBL] [Abstract][Full Text] [Related]
30. Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.
Stefancikova L; Moulis M; Fabian P; Ravcukova B; Vasova I; Muzik J; Malcikova J; Falkova I; Slovackova J; Smardova J
Int J Oncol; 2010 Mar; 36(3):699-706. PubMed ID: 20126990
[TBL] [Abstract][Full Text] [Related]
31. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
32. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y; Suzuki R; Tobinai K; Matsuno Y; Ichinohasama R; Okamoto M; Yamaguchi M; Tamaru J; Uike N; Hashimoto Y; Morishima Y; Suchi T; Seto M; Nakamura S
Blood; 2000 Apr; 95(7):2253-61. PubMed ID: 10733493
[TBL] [Abstract][Full Text] [Related]
33. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.
Williams ME; Swerdlow SH; Meeker TC
Leukemia; 1993 Sep; 7(9):1437-40. PubMed ID: 8371593
[TBL] [Abstract][Full Text] [Related]
34. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
35. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME
Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645
[TBL] [Abstract][Full Text] [Related]
36. Characterization of 4 mantle cell lymphoma cell lines.
Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
[TBL] [Abstract][Full Text] [Related]
37. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
[TBL] [Abstract][Full Text] [Related]
38. Correlation between mutations in p53 gene and protein expression in human lymphomas.
Martinez-Delgado B; Robledo M; Arranz E; Infantes F; Echezarreta G; Marcos B; Sanz C; Rivas C; Benitez J
Am J Hematol; 1997 May; 55(1):1-8. PubMed ID: 9136910
[TBL] [Abstract][Full Text] [Related]
39. Studies of the p53 gene mutation in Saudi non-Hodgkin's lymphoma.
Ahmad MF; Nasrin N; Akhtar M; Hannan MA
Cancer Lett; 1996 Jul; 104(2):225-31. PubMed ID: 8665492
[TBL] [Abstract][Full Text] [Related]
40. Implication of cyclin D1 in malignant lymphoma.
Callanan M; Leroux D; Magaud JP; Rimokh R
Crit Rev Oncog; 1996; 7(3-4):191-203. PubMed ID: 9258602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]